Michael K Sullivan
Overview
Explore the profile of Michael K Sullivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walker H, Khan S, Padmanabhan S, Pell J, Lewsey J, Mackay D, et al.
BMC Nephrol
. 2025 Mar;
26(1):113.
PMID: 40038631
Background: NICE guidelines recommend GPs use the kidney failure risk equation (KFRE) to identify people with chronic kidney disease (CKD) at higher risk of kidney failure. Albuminuria results are required...
2.
Walker H, Sullivan M, Jani B, Gallacher K
Br J Gen Pract
. 2025 Feb;
75(752):104-106.
PMID: 40016109
No abstract available.
3.
Elyan B, Sullivan M, Hedley J, De La Mata N, Webster A, Venugopal B, et al.
BJC Rep
. 2024 Nov;
2(1):57.
PMID: 39516651
Background: Drugs targeting angiogenesis and immunotherapy have transformed outcomes in renal cancer but may contribute to progressive kidney disease. Methods: We linked healthcare databases in the West of Scotland (spanning...
4.
Walker H, Sullivan M, Jani B, Mark P, Gallacher K
BMJ Open
. 2024 Oct;
14(10):e085843.
PMID: 39424379
Introduction: Clinical guidelines recommend the use of the kidney failure risk equation (KFRE) to guide the referral of individuals with chronic kidney disease (CKD) to secondary kidney care services. People...
5.
Walker H, Day S, Grant C, Jones C, Ker R, Sullivan M, et al.
BMC Med
. 2024 Oct;
22(1):452.
PMID: 39394084
Background: Prognostic models that identify individuals with chronic kidney disease (CKD) at greatest risk of developing kidney failure help clinicians to make decisions and deliver precision medicine. It is recognised...
6.
Sullivan M, Lees J, Rosales B, Cutting R, Wyld M, Woodward M, et al.
Am J Kidney Dis
. 2024 Jul;
84(6):731-741.e1.
PMID: 39053834
Rationale & Objective: Females have a higher prevalence of chronic kidney disease (CKD) than males but are less likely to be treated with kidney replacement therapy (KRT). We studied the...
7.
Shemilt R, Sullivan M, Hanlon P, Jani B, De La Mata N, Rosales B, et al.
Nephrol Dial Transplant
. 2024 Mar;
39(11):1799-1808.
PMID: 38460949
Background: People with chronic kidney disease (CKD) have increased incidence and mortality of most cancer types. We hypothesized that the odds of presenting with advanced cancer may vary according to...
8.
Jani B, Sullivan M, Hanlon P, Nicholl B, Lees J, Brown L, et al.
Br J Cancer
. 2023 Oct;
129(12):1968-1977.
PMID: 37880510
Background: In the United Kingdom (UK), cancer screening invitations are based on general practice (GP) registrations. We hypothesize that GP electronic medical records (EMR) can be utilised to calculate a...
9.
Lees J, De La Mata N, Sullivan M, Wyld M, Rosales B, Cutting R, et al.
Eur Stroke J
. 2023 Aug;
8(3):756-768.
PMID: 37641551
Purpose: We sought to explore whether adding kidney function biomarkers based on creatinine (eGFR), cystatin C (eGFR) or a combination of the two (eGFR) could improve risk stratification for stroke...
10.
Mayne K, Sullivan M, Lees J
J Hum Hypertens
. 2023 Jun;
37(8):649-653.
PMID: 37369830
No abstract available.